Uniphar plc, headquartered in Ireland (IE), is a leading player in the pharmaceutical and healthcare industry, specialising in the distribution of medicines and healthcare products. Founded in 1998, Uniphar has established a strong presence across Europe, particularly in Ireland and the UK, and has expanded its operations into various international markets. The company offers a diverse range of services, including supply chain management, clinical trial support, and commercialisation solutions for pharmaceutical companies. Uniphar's unique approach combines innovative technology with deep industry expertise, ensuring efficient delivery and compliance in a complex regulatory environment. Recognised for its commitment to quality and customer service, Uniphar has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. With a focus on enhancing patient outcomes, Uniphar continues to drive growth and innovation within the industry.
How does Uniphar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Uniphar's score of 54 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Uniphar reported total carbon emissions of approximately 6,023,660 kg CO2e, comprising 2,833,110 kg CO2e from Scope 1 and 3,190,550 kg CO2e from Scope 2. The previous year, 2023, saw emissions of about 6,328,900 kg CO2e, with Scope 1 emissions at 2,969,970 kg CO2e, Scope 2 at 3,358,930 kg CO2e, and a significant Scope 3 total of approximately 875,620,000 kg CO2e. Uniphar has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50% by 2030, using 2019 as the base year. Additionally, the company has pledged that 73.5% of its suppliers, based on emissions from purchased goods and services, will have science-based targets by 2027. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. The emissions data is sourced directly from Uniphar plc, with no cascading from a parent organization. The company is headquartered in Ireland and operates within the healthcare sector, focusing on healthcare providers and services, as well as healthcare technology.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 3,954,880 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,794,840 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | - |
Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 89% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Uniphar has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
